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Abstract
Background: Enveloped viruses including the simian immunodeficiency virus (SIV) replicating within host cells
acquire host proteins upon egress from the host cells. A number of studies have catalogued such host proteins,
and a few have documented the potential positive and negative biological functions of such host proteins. The
studies conducted herein utilized proteomic analysis to identify differences in the spectrum of host proteins
acquired by a single source of SIV replicating within CD4
+ T cells from disease resistant sooty mangabeys and
disease susceptible rhesus macaques.
Results: While a total of 202 host derived proteins were present in viral preparations from CD4
+ T cells from both
species, there were 4 host-derived proteins that consistently and uniquely associated with SIV replicating within
CD4
+ T cells from rhesus macaques but not sooty mangabeys; and, similarly, 28 host-derived proteins that uniquely
associated with SIV replicating within CD4
+ T cells from sooty mangabeys, but not rhesus macaques. Of interest
was the finding that of the 4 proteins uniquely present in SIV preparations from rhesus macaques was a 26 S
protease subunit 7 (MSS1) that was shown to enhance HIV-1 ‘tat’ mediated transactivation. Among the 28 proteins
found in SIV preparations from sooty mangabeys included several molecules associated with immune function
such as CD2, CD3ε, TLR4, TLR9 and TNFR and a bioactive form of IL-13.
Conclusions: The finding of 4 host proteins that are uniquely associated with SIV replicating within CD4
+ T cells
from disease susceptible rhesus macaques and 28 host proteins that are uniquely associated with SIV replicating
within CD4
+ T cells from disease resistant sooty mangabeys provide the foundation for determining the potential
role of each of these unique host-derived proteins in contributing to the polarized clinical outcome in these 2
species of nonhuman primates.
Background
The mechanisms by which non-human primate (NHP)
natural hosts of the simian immunodeficiency virus
(SIV) remain disease resistant, despite plasma viral loads
that in some cases far exceed the levels that lead to a
spectrum of disease and death (similar to untreated
HIV-1 infection of humans leading to AIDS) in non-
natural hosts, remain ill defined [1,2]. Thus while SIV
infected sooty mangabeys (SM) and > 40 other African
NHP species naturally infected with SIV to a large
extent remain disease resistant [3], select isolates from
the natural African hosts, when used to experimentally
infect non-natural Asian NHP such as rhesus macaques
(RM), invariably lead to disease and death [4]. It has
been known for some time that enveloped viruses
including HIV-1 and SIV interact with and incorporate
a variety of host molecules during the various phases of
the life cycle of these viruses within the host cell [5].
Thus, as these virions bud and pinch off the plasma
membrane of the host cells, they have been shown to
* Correspondence: pathaaa@emory.edu
1Department of Pathology & Laboratory Medicine, Emory University School
of Medicine, Atlanta, GA 30322, USA
Full list of author information is available at the end of the article
Stephenson et al. Retrovirology 2010, 7:107
http://www.retrovirology.com/content/7/1/107
© 2010 Stephenson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.carry with them parts of the plasma membrane contain-
ing host proteins some of which remain stably asso-
ciated with the virions. The role these host proteins play
while associated with the virions on the infectivity of the
virus and/or on the host immune system remains
incompletely understood. These findings prompted us to
hypothesize that perhaps differences in the nature of the
host proteins that interact with and are incorporated by
SIV during its life cycle within cell lineages of the dis-
ease resistant SM as compared with disease susceptible
RM could contribute to the distinct clinical outcome of
SIV infection of these two species.
The pioneering studies aimed at the characterization of
host proteins incorporated by lentiviruses were per-
formed by the laboratories of Dr. M Tremblay and high-
lighted the potentially important role such host proteins
can play in the pathogenesis of human HIV-1 infection
[6]. The initial studies were focused on identifying the
mere physical presence of host proteins that had pre-
viously been identified as playing a role in immune func-
tion [7,8]. These studies were soon followed by reports
showing that several of these host proteins, such as the
MHC class II proteins, ICAM-1, CD28 and CD40L,
indeed could enhance the infectivity of the virions, for
some as much as 20 to 100-fold with target cells that
expressed the cognate receptors for such molecules
[9-13]. In addition, the finding of select host encoded cell
adhesion molecules (CAMs) within HIV-1 virions further
supported the view that the presence of the previously
mentioned immunological receptors along with CAMs
could facilitate enhanced cell-cell interaction and thus
enhance infectivity of the viruses for target cells that
expressed receptors for such CAMs [14,15]. In addition
to enhancing viral infectivity, there were also reports of
the ability of some of the HIV associated host molecules
such as MHC-class II and B7-2 present on both infec-
tious and non-infectious virions to transduce signals that
would promote apoptosis of cells bearing receptors for
such host proteins [16,17]. The fact that only 0.01 to
0.00001% of the virions in any given virus preparation are
in fact infectious suggests that the biological role of such
host proteins within inactive virions may play an impor-
tant role in inducing immune dysfunction characteristic
of lentivirus infections [18]. The first detailed study
aimed at cataloging the types of host proteins that
become associated with HIV-1 was performed by Cher-
tova et al. [19] who utilized LC/MS/MS analysis of HIV-
1 preparations isolated from infection of enriched popu-
lations of human monocyte derived macrophages. A
rather substantial list of > 250 host proteins were identi-
fied along with 26 of the 37 host proteins previously
found to be associated with exosomes.
These findings prompted further studies aimed at
defining a) the pathways and the energy barrier being
utilized by HIV to bud and egress from cell lineages
with the identification of lipid rafts and the virological
synapse as being preferentially utilized by HIV-1
[20-22], b) the contribution of microvesicles present in
the virus preparations that were being utilized for the
analysis of host proteins [23], c) whether the host pro-
teins non-specifically adhere onto the virus or are incor-
porated within the virus [8,24], and d) the use of more
sophisticated and ultrasensitive techniques such as LC-
MS/MS to detect the presence of such host proteins
[25]. A number of other non-proteomic genome-wide
association screening (GWAS) assays utilizing RNA
silencing techniques have also been utilized to identify
the nature of the host proteins that play critical roles in
the life cycle of HIV infection, integration, replication
and budding [26-28]. These transient RNA silencing
techniques using HeLa/293T cell lines has led to the
identification of approximately 272, 278 and 304, to a
large extent non-overlapping candidate human genes,
that play varying roles in the HIV-1 life cycle. The fact
that while these cell lines are relatively easy to perform
siRNA transfection studies, but are not the most optimal
to study HIV-1 infection that primarily targets T cells
prompted Yeung et al. [29] to utilize the JURKAT cell
line. These authors capitalized on the availability of a
shRNA library that targets 54,509 human targets and
prepared a large series of JURKAT cloned T cell lines
each containing a discrete shRNA and infected these
with HIV-1. Such studies led to the identification of 252
host proteins that were critical for HIV-1 replication
[29]. In addition, similar series of cataloging studies led
to the establishment of a HIV-1 ‘tat’ human nuclear
interactome [30], and a HIV-1 Human Protein Interac-
tion Database (HHPID) that is readily available at the
NCBI website http://www.ncbi.nlm.nih.gov/RefSeq/
HIVInteractions and lists a total of 1435 human genes
and 2589 unique HIV-1 protein to host cell protein
interactions [31].
The purpose of the studies reported herein was to
take advantage of the above findings but focus the stu-
dies at the identification of differences in the nature of
host proteins incorporated by SIV virions generated by
replication within primary CD4
+ T cells from disease
susceptible RM and disease resistant SM. Data presented
herein document the identity of host proteins that are
uniquely associated with virions from the 2 species of
NHP. The potential role of the proteins identified in
contributing to the polarized clinical outcome of SIV
infection in the 2 species is discussed.
Results
In efforts to ensure that the identification of the host
proteins incorporated by the virions reflected the phy-
siologically “normal” complement of host proteins, we
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transformed cell lines. Thus, a series of primary day 3
Con-A blasts from 3 individual rhesus macaques (RM)
and 3 individual sooty mangabeys (SM) were utilized for
infection with a SIVdelTable 670 sub-stock, which repli-
cated well in cells from both species. A single pool of
the virus preparation from individual monkeys was puri-
fied as outlined in the methods section, and aliquots
were subjected to studies detailed below.
Characterization of the virus preparation
As previously documented, the virus preparations when
examined by electron microscopy were shown to con-
tain 1-5% virions and large amounts of vesicles and cell
debris. A virion purification procedure was therefore
utilized using a commercial Fast trap column kit, which
led to highly enriched preparation of virus with no
detectable vesicles and minimal cell debris. Aliquots of
virus preparations from each of the 3 SM and 3 RM
were subjected to protein determination, analysis of the
levels of p27, relative levels of infectivity (TCID50), and
number of viral copies using quantitative PCR prior to
the proteomic analysis. Table 1 summarizes the results
from these analyses. As seen, while there was consider-
able amount of variation in the values obtained with
each of the assays performed, overall there does appear
to be similar distribution of values in the virus prepara-
tion from the 2 species of monkeys when comparing
p27 levels, TCID50 or number of viral copies. It is
important to keep in mind that the same amount of
total protein from each of the 3 RM and each of the 3
SM was subjected to analysis and, in addition, the data
obtained by proteomic analysis from each sample was
analyzed in context with the differences in the values.
Gel analysis
Aliquots (30 μg) of the virus preparation from each of
the SM and RM were subjected to 4 to 20% SDS-PAGE
analysis in efforts to initially resolve the heterogenous
group of proteins. A representative gel profile from the
v i r u sp o o l sf r o mar e p r e s e n t a t i v eR Mm o n k e yi s
depicted in Figure 1. Each of the virus pool from each
of the RM and SM gave the same general profile. As
seen, there were consistently 4 major bands at approxi-
mately 25-30, 60, 100-120 and 250 kDa and a total of
12 additional low and variable intensity bands. The gels
were then sliced into 16 similar slices containing these
regions (see Figure 1) and each slice subjected to pro-
teomic analysis.
Proteomic analyses
Data obtained on the spectrum of both viral and host
peptides from each gel region of each virus preparation
Table 1 Characterization of the pools of virus prepared
from primary cultures of CD4+ T cells from rhesus
macaques (RM) and sooty mangabeys (SM)
Monkey
Species
and ID
Protein
(ng/ml)
Levels of
p27 (ng/ml)
TCID50
I.U./ml
Viral copy #
x1 0
7 per ml
SM-FYy 784.8 119.41 2.2355 3.13
SM-FMy 474.6 63.03 1.1771 2.76
SM-FJt 384.8 48.7 4.1347 3.83
RM-RDd3 1786.9 351.18 4.9960 2.75
RM-RVe7 1059.4 151.30 2.5674 2.79
RM-RLg10 557.6 69.30 1.2364 2.55
Figure 1 Representative SDS-PAGE profile of SIV preparations.
A representative SDS-PAGE profile of a virus preparation from CD4
+
T cells from a rhesus macaque. The resulting gel was sliced into
fragments as indicated by the boxes and subjected to proteomic
analysis for the identification of host proteins.
Stephenson et al. Retrovirology 2010, 7:107
http://www.retrovirology.com/content/7/1/107
Page 3 of 15were first entered into a database which could facilitate
identifying a list of the different types and the total
number of putative proteins that were present in any of
the virus preparation from the 2 species of monkeys as
described in the methods section. Use of part of the
database ftp://ftp.ncbi.nih.gov/refseq/release/vertebrate_-
mammalian/ for analysis led to the identification of each
of the viral proteins (gag-pol polyprotein, env, gag, pol,
vif, vpx, vpr, rev, tat and nef). Please note that p27 was
not detected in the database search, which we reason is
due to the fact that trypsin was used to fragment the
proteins, and p27 does not contain a trypsin excision
site. However, the presence of p27 in each of the virus
preparations was verified by ELISA. Analysis of the data-
bases generated from our study led to the identification
of a total of 1979 host proteins (see additional file 1)
that were present in viral preparations from any of the 3
RM or any of the 3 SM. These results were then sub-
jected to further analysis to identify those host proteins
that were present in viral preparations from both of the
3S Ma n d3R M( c o m m o nt ov i r u sp r e p a r a t i o n sf r o m
both the monkey species) (additional file 2) and those
that were uniquely present consistently in the virus pre-
paration from each of the 3 RM but none of the SM
(Table 2), and those that were uniquely present in virus
preparations from each of the 3 SM but none of the
RM (Table 3).
This analysis led to the identification of 202 viral and
host encoded proteins that were identified in virus pre-
parations from both SM and RM (additional file 2),
which is in contrast to the total of 328 proteins identi-
fied by Chertova et al. in preparations of HIV-1 [19],
although these latter studies employed macrophages
for their preparation of the HIV-1. As stated above,
each of the virus-encoded proteins was identified. In
efforts to facilitate an understanding of the potential
roles of the host proteins, these data were divided into
proteins which represent a) the cytoskeleton (n = 49),
b) extracellular matrix (n = 14), c) ribosomal proteins
(n = 18), d) proteasome associated (n = 19), e) those
involved in intracellular signaling (n = 9), f) those
involved in cell metabolism (n = 33), g) those involved
in intracellular trafficking (n = 5), h) those associated
with coagulation (n = 6), i) those proteins found in the
nucleus (n = 8), and j) those with direct or indirect
immunological function (n = 21). Thus, as seen in
Figure 2 the most abundant group of host proteins pre-
sent in virus preparations as expected were the cytos-
keletal proteins (24.3%), followed by those involved in
cell metabolism (16.3%), and of interest a high fre-
quency of proteins involved in immune function
(10.4%) which included the cell surface proteins and
high levels of the MHC-class I and II molecules, CD44
and CD109 molecules.
As stated above, our major goal in the analyses of the
host proteins in the viral preparations was to identify
those that are consistently differentially expressed by
virus preparations from each of the SM but not RM,
and each of the RM but not SM. The database was thus
analyzed to identify those proteins that were uniquely
present in virus preparations from each of the 3 RM,
but not SM and vice versa. Surprisingly, such analyses
led to the identification of only 4 host proteins uniquely
present in virus preparation from each of the 3 RM, but
not in any of the virus preparations from the SM. On
the other hand 28 proteins were found to be uniquely
present in virus preparations from each of the 3 SM but
not any of the RM (Tables 2 and 3). The 4 proteins
uniquely identified in viral preparations from each of
the 3 RM included a 26 S protease regulatory subunit 7
protein. This 26 S protease is involved in the ATP-
dependent degradation of ubiquitinated proteins [32].
The regulatory (or ATPase) complex confers ATP
dependency and substrate specificity to the 26 S com-
plex. It has been demonstrated that the 26 S protease
regulatory subunit 7 (MSS1 protein) enhances the HIV-
1 ‘tat’-mediated transactivation [33] and associates with
basal transcription factors [34,35] suggesting its role in
transcriptional regulation. There is also evidence that
the 19 S regulatory complex or its subunits functions as
mediators of transcriptional systems through their asso-
ciation with promoters, facilitating the clearance of
paused elongation complexes, and recruitment of co-
activators [36-40]. A recent study also suggested that
the proteasome regulates HIV-1 transcription by both
proteolytic and nonproteolytic mechanisms [40]. The
second protein identified was APG7, which is an E1 like
protein involved in autophagy by facilitating the net-
working of 2 ubiquitin like proteins APg12 and APg8 to
associate with E2 enzymes. The third protein identified
Table 2 List of host proteins uniquely found in virus from Rhesus macaques (RM) not Sooty Mangabeys (SM)
Host Proteins in only
RM-derived Virus
Reference Number Category
26 S protease regulatory subunit 7 (MSS1 protein) XP_001118305.1 Ubiquitination, HIV transcription
APG7 autophagy 7-like isoform 4 XP_001088170.1 Ubiquitination
Mitogen-activated protein kinase kinase kinase kinase 1 XP_001082963.1 Intracellular signaling
Tripartite motif-containing 45 isoform 3 XP_001113153.1 Intracellular signaling
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Host Proteins in only
SM-derived SIV
Reference Number Category
2,4-dienoyl CoA reductase 1 XP_001085155.1 metabolism
40 S ribosomal protein S7 (S8) XP_001095908.1 ribosome
Aldo-keto reductase family 1 member C1 tr|Q0R409|Q0R409_MACFA metabolism
CD3e molecule, epsilon (CD3-TCR complex) XP_001097204.1 immune function associated
Chloride intracellular channel 4 isoform 3 XP_001106485.1 membrane/cytoskeleton
Clathrin, heavy polypeptide-like 1 XP_001112729.1 membrane/cytoskeleton
Cluster of differentiation 2 (CD2) tr|Q6SZ59|Q6SZ59_CERTO immune function associated
Collagen, type X, alpha 1 precursor isoform 1 XP_001112083.1 extracellular matrix
Complement factor I precursor (C3B/C4B inactivator) XP_001087512.1 immune function associated
Cryptochrome 2 (photolyase-like) XP_001113162.1 nuclear protein
Disulfide-isomerase A3-like protein tr|A6ML76|A6ML76_CALJA immune function associated
Fc receptor-like and mucin-like 2 isoform 3 XP_001118137.1 immune function associated
Filamin B, beta (actin binding protein 278) isoform 3 XP_001097922.1 membrane/cytoskeleton
Gamma-aminobutyric acid (GABA) A receptor, beta 2 isoform 1 isoform 2 XP_001085738.1 neurotransmission
Glutamate receptor 1 sp|Q38PU8|GRIA1_MACFA neurotransmission
Guanine nucleotide binding protein-like 3 (nucleolar)-like isoform 2 XP_001090251.1 nuclear protein
HBS1-like isoform 3 XP_001100221.1 immune function associated
Integrin alpha-V XP_001104012.1 immune function associated
Interleukin-13 tr|Q0ZB84|Q0ZB84_CERTO immune function associated
MAWD binding protein XP_001086075.1 immune function associated
Programmed cell death protein 6 XP_001119112.1 immune function associated
Quiescin Q6 isoform a XP_001111489.1 immune function associated
Ribosomal protein L35a XP_001082551.1 ribosome
Toll-like receptor 4 tr|B6CJZ3|B6CJZ3_CERTO immune function associated
Toll-like receptor 9 tr|B6CK02|B6CK02_CERTO immune function associated
Transcription elongation factor A (SII)-like 4 XP_001085077.1 nuclear protein
Tropomyosin 4 isoform 2 XP_001092183.1 membrane/cytoskeleton
Tumor necrosis factor receptor superfamily, member 17 isoform 1 XP_001106826.1 immune function associated
Figure 2 Categories of host proteins associated with SIV preparations. The general characterization of the function of the spectrum of host
proteins expressed as a percentage of the total (n = 202) that were identified to be present in viral preparations from CD4
+ T cells from each of
the three rhesus macaques and sooty mangabeys.
Stephenson et al. Retrovirology 2010, 7:107
http://www.retrovirology.com/content/7/1/107
Page 5 of 15was the mitogen protein kinase kinase kinase kinase 1
protein involved in cell signaling. The fourth protein
identified was TRIM45, which is part of the Tripartitie
motif-containing proteins and is thought to serve as a
repressor of mitogen activated protein kinase signaling
pathway [41]. Thus, these proteins appear to be either
involved in ubiquitination or intracellular signaling, with
one of them shown to play an important role in HIV-1
transactivation.
As indicated above, the viral preparations from each of
the 3 disease resistant SM contained a 7-times higher
number of host proteins that were not identified in viral
preparations from the disease susceptible RM. This list
of proteins was analyzed for their respective function
with a bias to define those that have the potential to be
involved directly/indirectly with some aspect of immune
function. The analysis led to the identification of 14/28
(50%) proteins being directly and/or indirectly involved
in immune function, followed by 5 that were classified
as being structural and/or membrane associated
proteins, 3 that were nuclear proteins, and 2 each
involved in cell metabolism, ribosomal proteins, and
neurotransmitter proteins. The “immune function
related” virus-associated host cell proteins contained
important mediators of T cell signaling. Thus, the CD3ε
is part of the T cell receptor (TCR) complex and is the
main chain that interacts with the TCR [42] and the
level of its expression shown to be influenced by disease
status in HIV-1 infected individuals [43] resulting in
T cell receptor signaling [44]. It is possible that its pre-
sence is somehow associated with interference of TCR
signaling and thus needs further study. The TNFR
superfamily members control diverse aspects of immune
function including those mediated by OX40/OX40L
interactions. Such interactions regulate CD4
+ and CD8
+
T cell, NK-T cells, and NK cell function as well as med-
iating cross talk with antigen presenting cells [45]. The
CD2 molecule belongs to the immunoglobulin super-
f a m i l yo fm o l e c u l e sa n dh a sb e e ns h o w nt os e r v ea sa
cell adhesion molecule with LFA-3 (CD58) serving as its
ligand [46]. It is expressed by T cells and NK cells and
has also been shown to serve a co-stimulatory function
[47]. The finding of C3b/C4b inactivator protein is
clearly of importance since it is a potent inhibitor of the
complement cascade and thus could play a major role
in inhibiting the lysis of anti-SIV reactive antibodies.
The FcR like and mucin-like protein identified is remi-
niscent of FcRY, an FcR related gene, which is differen-
tially expressed during B lymphocyte development and
activation [48]. The integrin a5 has been shown to be
involved in the differentiation of osteoblasts from
human bone marrow derived mesenchymal stem cells
[49] and hypothesized to similarly induce the differentia-
tion of the monocytoid lineage of cells. Presumably, its
presence within the virus particle may be responsible for
the accelerated differentiation of these lineages of hema-
topoietic cells. Of all the immunologically related pro-
teins identified, the presence of CD2, CD3-ε,I L - 1 3 ,
TLR4, TLR9 and the TNFR proteins were thought to be
of great interest. Thus, IL-13 is an immuno-regulatory
cytokine, which is secreted primarily by Th2 type of
helper T cells, and its major role has been shown to
involve allergic diseases and immune responses against a
number of parasites [50,51]. In addition, IL-13 has been
shown to play an important role in the biology of intest-
inal epithelial cells [52], which are the primary target tis-
sue for both HIV and SIV. Thus, IL-13 has been shown
to modulate mucosal epithelial cells by increasing the
expression of the pore forming tight junction molecule
termed claudin-2 [53]. These findings are of interest in
light of the findings of HIV-1 induced dysregulation of
claudin-2 in human epithelial cells [54] and its potential
role in promoting bacterial translocation [55]. Thus, the
IL-13 present in virus replicating in disease resistant SM
could be inducing increased claudin-2 synthesis to
rapidly repair the damage induced by SIV in the gut
mucosa. The presence of TLR-4 in this regard is also of
interest since TLR-4 has been shown to be involved in
host defense including its role within the gut tissue by
responding to LPS and LPS-like ligands and preventing
bacterial translocation [56], which has been implicated
as playing a major role in inducing chronic immune
activation characteristic of pathogenic but not apatho-
genic HIV/SIV infection [57]. TLR-9, like TLR-7, is a
receptor that is activated by nucleic acids or CpG con-
taining immuno-stimulatory motifs. Thus, bacterial and
viral infections can induce TLR activation with a num-
ber of immunological and hematopoietic consequences.
These include the release of a number of cytokines and
chemokines but also result in protection from apoptosis
of plasmacytoid dendritic cells (pDC’s). This issue is
important since both bacteriala n dv i r a li n f e c t i o n sn o t
only activate TLR’s but also result in the synthesis of
glucocorticiod hormones (GC), which are immunosup-
pressive and lead to apoptosis of pDC’s. However, liga-
tion of the TLR7/9 by the CpG like motifs results in the
upregulation of the anti-apoptotic genes Bcl-2, Bcl-xl,
BIRC3 and CFLAR [58] resulting in survival of the
pDC’s and preserving the pro-inflammatory pathway
leading to protective immune responses. With regards
to apoptosis, it is of interest to find the presence of
Quiescin 6 in the virions, which is a protein involved in
the protection from apoptosis secondary to oxidative
stress [59]. The other proteins identified include those
that are involved with the gastro-intestinal (GI) tract
and include a) disulphide isomerase A3 which has been
s h o w nt ob eac a t a l y t i ce n z y m et h a tr e a r r a n g e sd i s u l -
phide bonds in proteins and contribute to immune
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shown to be upregulated during alloimmune responses
[61], b) MAWBP which is one of the gastric proteins
involved in gastric cancer and its ligand MAWD [62]
which is known to interact with both the TGF-b recep-
tor and Smd 7 resulting in the inhibition of TGF-b sig-
naling [63]. Finally, it is of interest to note the presence
of HBS1, which is an intracellular protein involved in
mRNA degradation but is also related to translation fac-
tors through direct contact with ribosomes and related
to Ski7, which is an accessory molecule to exosomes
[64]. Exosomes have been implicated as Trojan horses
for the pathogenesis of HIV-1 infection [65,66].
Bioassays
The identification of the presence of proteins such as
MSS-1 in SIV from each of the 3 RM but none of the 3
SM and IL-13, TLR 4, TLR9 and TNFR in SIV from
each of the SM but none of the 3 RM prompted us to
confirm their presence using either bioassays and/or
Western Blot assays. Unfortunately, none of these mole-
cules could be detected in the purified virus prepara-
tions by standard Western Blot assays, which was not
due to technical issues since positive controls (recombi-
nant proteins) utilized in parallel showed readily detect-
able bands. We reason that such failure was likely a
result of either denaturation of these proteins secondary
to the techniques utilized to prepare highly purified pre-
parations of the virus or due to the limits of the detec-
tion by the Western Blot assay. However, we were able
to demonstrate that indeed MSS-1 derived from RM
does enhance HIV-1 ‘tat’ mediated transactivation
(Figure 3). In addition, preliminary studies appear to
indicate that CD4
+ T cells from RM appear to contain
10-20 times more MSS-1 as compared with similar
number of CD4
+ T cells from SM which we submit
could account for its differential incorporation in
SIV from RM. Another assay that appeared to pro-
vide meaningful results was the assay for IL-13, as
described in the methods section. The results as shown
in Figure 4 show that I μg of virus preparation from
each of the 3 virus preparations from the CD4
+ T cells
of SM contained variable amounts of bioactive IL-13.
The fact that a monoclonal anti-IL-13 antibody (1/50
dilution) neutralized the bioactivity indicated an element
of specificity for the detection of the IL-13 in the virus
preparation. No detectable IL-13 bioactivity was noted
in the virus preparations from each of the 3 RM (< 5
pg/ml) even when 5 μg of the virus preparation from
these monkeys was used in the same assay run in
parallel.
Taken together, the above data indicate that SIV repli-
cating in primary CD4
+ T cells from SM appears to
incorporate a wide array of host proteins as compared
with the same virus replicating in primary CD4
+ T cells
from RM. Of importance was the finding that while a
large number of these host proteins uniquely associated
with SIV generated from CD4
+ T cells from SM appear
to be directly and/or indirectly related to immune func-
tion, those few that are uniquely associated with SIV
from RM are involved with promoting ‘tat’ mediated
transactivation of HIV-1, autophagy and intracellular
signaling. How such proteins contribute to the polarized
clinical outcome of infection in these 2 species remains
to be defined and is a subject of future studies.
Discussion
The incorporation of host proteins by enveloped virions
while they are being packaged within a cell and as they
exit from the cell are reasoned to be acquired by the vir-
ions as a result of intra-cellular interactions between the
various viral proteins and the host proteins [67]. These
interactions facilitate the life cycle of the virus and in
some cases play an integral role in the escape of the
virus from normal host defenses. There are several
other proteins incorporated by the virions in fact that
h a v eb e e ns h o w nt op l a ya na c t i v er o l ei nv i r a le n t r y ,
integration, transcription, assembly and budding [5,68].
It is important to distinguish host proteins that “inter-
act” with viral proteins and are required and/or facilitate
specific stages of the viral life cycle from those host pro-
teins that are “incorporated” by the virions during the
various stage of its life cycle. An example of the former
is the recent characterization of 19 host proteins that
appear to specifically interact with the pre-integration
complex (PIC) of HIV-1 [69]. A large number of host
proteins that “interact” with select HIV-1 proteins such
as HIV-1 ‘tat’ [30] and others that are required for viral
entry, reverse transcription, integration, transcription,
packaging and exit from the cell are exemplified by the
findings of a series of studies that utilized siRNA and
shRNA technologies. The study utilizing siRNA has led
to the identification of 273 host proteins that have been
termed Host Dependency Factors (HDF) that are
required for HIV to infect, replicate and package within
ap e r m i s s i b l eh o s tc e l l[ 2 6 ] .T h es t u d yu t i l i z i n gs h R N A
capitalized on the availability of a library of 54,509
shRNA led as described above to the identification of
252 human candidate genes that play a role in HIV-1
infection [29]. Of interest is the finding of a relative lack
of similarity in the spectrum of host proteins that have
been catalogued by such approaches. It is reasoned that
while there are clear benefits with using such cell lines,
the transformed nature and non-physiological relevance
of these cell lines as targets of HIV-1 infection and
replication may be the basis for the results obtained.
When we analyzed the data reported herein (additional
file 1) with the databases compiled by the other studies,
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273 described by Brass et al. [26], 54/183 described by
Gautier et al. [30] and 40/252 described by Yeung et al.
[29] as summarized under Table 4. A list of the host
proteins found common between the studies described
herein and those by Chertova et al.[ 1 9 ] ,B r a s set al.
[26], Gautier et al. [30] and Yeung et al. [29] is provided
under the additional files 3, 4, 5 and 6.
It is beginning to become clear that a number of these
host cellular proteins that become “associated” or
“incorporated” by the virus as they exit from the cell
can not only influence the biology of the virus (by
increasing or decreasing its level of infectivity) but may
also function to enhance or suppress immune responses
in vivo [70]. While a number of elegant studies have
been published on the characterization of host proteins
that are associated with HIV-1, the primary purpose of
the studies reported herein were focused on determining
whether an aliquot of the same virus stock that repli-
cates well and quite similarly within CD4
+ T cells from
both species included in the present study would differ-
entially acquire host proteins during replication, assem-
bly and egress from cells from disease resistant sooty
mangabeys (SM) as compared with the same cell lineage
from the disease susceptible rhesus macaques (RM). It
should be emphasized that we utilized cultures of pri-
mary CD4
+ T cells thus eliminating the potential arti-
facts introduced with the use of transformed cell lines,
although the cell lines do p r o v i d eal a r g e rs o u r c eo f
virus and are relatively easy to prepare. As stated above,
our studies were designed as such to primarily identify
those proteins that are exclusively associated with either
pathogenic or apathogenic course of SIV infection,
which could lead to an elucidation of some of the
pathogenic mechanism underlying SIV disease.
There are several issues that need to be addressed
with regards to the studies reported herein, including a)
the validation that indeed the proteins identified are
truly associated with the virus preparation and not a
contaminant, b) whether any of the proteins identified
demonstrate function, c) reasons for the marked
increases in the number of proteins identified in the SIV
prepared from SM versus RM, d) the biological rele-
vance of the proteins identified, and e) the relative sensi-
tivity and specificity of the findings of our studies. These
are each addressed below.
One of the most important issues with studies related
to the identification of host proteins in viral prepara-
tions is to distinguish those host proteins that are mere
Figure 3 Enhancement of HIV-1 ‘tat’ mediated transactivation
by rhesus MSS-1. Aliquots of the TZM-bl cell line were transfected
with either 0.2 μg of HIV-1 ‘tat’ expression plasmid alone, 0.8 μgo f
MSS-1 expression plasmid alone, or both and dispensed into
individual wells of a 96-well microtiter plate (5000 cells/well) in
media for 48 hr. Each assay was performed in triplicate. B-
galactosidase activity was then determined using the Tropix Gal-
screen assay kit and the results expressed as mean RLU/sec. The
data shown are representative of 3 separate experiments. The S.D.
of the 3 cultures was all < 10%.
Figure 4 Presence of functional IL-13 in the SIV preparations from sooty mangabeys. Assay for IL-13 bioactivity in virus preparations from
CD4
+ T cells from each of the three sooty mangabeys (SM). The assay was performed as described in the methods section. The values M1, M2,
and M3 to the left reflect levels of IL-13 in virus preparations from the 3 SM, and the values to the right are those with the addition of 1/50
dilution of a monoclonal anti-IL-13 antibody. The S.D. of each value shown was < 10%. The lower limits of this assay were determined to be 5
pg/ml using recombinant human IL-13.
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with proteins that are truly part of the virions. To
address this issue, our laboratory conducted a series of
studies designed to isolate as pure a virus preparation as
technically possible. This required removal of cell debris
and other contaminants as outlined in the methods sec-
tion. Electron micrographic analysis of the virus pre-
parations prior to and post virus purification (see
additional file 7) shows the degree of purity achieved
using the strategy outlined. Studies on the level of p27
and number of viral copies per mg protein showed a
> 100-fold increase per mg total protein in the levels of
p27 and SIV viral copies recovered following purifica-
tion (Figure 5A and 5B). The fact that this purification
protocol resulted in the almost complete removal of cell
debris provides some degree of assurance that indeed
the host proteins identified are highly likely to be asso-
ciated with the virions and not mere contaminants. Sec-
ondly, it is to be noted that the fact that the host
proteins identified uniquely associate with virus prepara-
tions from each of the 3 SM but NONE of the virus
preparations from all 3 RM and vice versa strongly sug-
gests an element of specificity. It is clear that additional
studies of the role these host proteins play in viral host
interactions may provide added confidence that indeed
their presence is not an artifact. As far as function is
concerned, we were successful in demonstrating that the
MSS-1 protein from RM did show marked enhancement
of HIV-1 ‘tat’ mediated transactivation (Figure 3) which
is likely due to the finding of the presence of
Table 4 Analysis of host proteins identified in SIV replicating in primary CD4+ T cells from rhesus macaques and sooty
mangabeys that have been previously found also to interact with and/or be present in HIV-1 preparations
Type of Analysis Host cell utilized Number of host proteins present in SIV/referenced
study
Reference
Host proteins in HIV-1 preparation Human primary
macrophages
79/253 [19]
GWAS type of study using shRNA/HIV-1 HeLa 37/273 [26]
Host proteins
interacting with HIV-1 tat
Jurkat 54/183 [30]
Host proteins contributing to productive HIV-1
replication
Jurkat 40/252 [29]
Figure 5 Analysis of viral copies and levels of p27 in the virus preparations prior to (Pre) and following enrichment (Post). An aliquot
of the pooled virus from 2 SM (FYy and FJt) and 3 RM (RDd3, RVe7 and RLg10) was analyzed for the number of viral copies and levels of p27
prior to and post enrichment. Values shown reflect (A) number of viral copies per mg of total protein and (B) μg of p27 per mg of total protein.
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+ T cells
from RM as compared with SM. In addition, we were
also able to document the presence of IL-13 bioactivity
(Figure 4) in virus preparation from SM but not RM,
which supports the view that at least some of the host
proteins identified could be contributing to differences
in the clinical outcome of SIV infection in these 2 spe-
cies. With regards to the reasons for the increased num-
bers of host proteins that were identified in the virus
preparation from SM as compared with RM, it is impor-
tant to note that our laboratory has previously shown
that CD4
+ T cells from SM are resistant to undergo
anergy [71] and requires a minimal or no second signal
for T cell responses. It is our hypothesis based on these
findings that perhaps, CD4
+ Tc e l l sf r o mS Mr e m a i ni n
culture longer than CD4
+ Tc e l l sf r o mR M ,w h i c h
allows a longer time period for virus to replicate within
this cell lineage. On the other hand it should also be
n o t e dt h a tS Mh a v eam a r k e d l yl o w e rf r e q u e n c yo f
CCR5 expressing CD4
+ T cell subset [72] and a skew in
the predominance of the TH2 subset [1]. Thus, such dif-
ferences may promote the replication of SIV within dif-
ferent subsets of CD4
+ T cells from SM and RM
resulting in the differences in the complement of host
proteins that become associated with the virus. This line
of reasoning implies that CD4
+ T cells from SM include
the CD4
+ T cell subset present in RM in which the
virus replicates and thus cancels out the long list of pro-
teins that were found to be associated with virus pre-
parations from RM. It is important to point out that
there was no shortage in the number of host proteins
that were found to be associated with virus preparations
from RM but the studies herein were focused on identi-
fying only those that were uniquely associated with the
species. In this regard, it is also important to keep in
mind that while the list of proteins identified is large, it
is clear that it is impossible for each virion to include all
of these host proteins. In addition, the virus prepara-
tions contain a heterogenous selection of viruses, which
may contain variable amounts of each of these proteins.
As such, we are identifying what is more or less an aver-
age group of host proteins that get associated with the
virus from each of the 2 species.
One of the most important issues concerning these studies
is the biological significance of the findings. Clearly as has
been previously described the presence of virus-associated
host proteins are of significant consequence as they can
serve to a) promote cell to cell transmission of the virus
[14], b) induce NF-B and NFAT activation [16], c) the
virions can act as antigen presenting cells since they con-
tain both intact MHC class II and CD86 [73] and d) con-
tain a long list of molecules involved in the induction and
regulation of immune responses including HLA-Dr,
ICAM-1, CD40, CD40L and CD86 [13]. In addition, select
molecules present within these viruses also have been
implicated in inducing immunosuppression and contribut-
ing to innocent bystander apoptosis highlighting the
potential important role such host proteins can play in the
pathogenesis of HIV/SIV infection. Germane to the pre-
sent studies, it is important to identify a specific biological
role for proteins uniquely found in virus preparations
from the RM and the SM in efforts to determine their role
in disease susceptibility/resistance. In this regard, it is
important to highlight the role of the host protein MSS1
that was found to be uniquely associated with virus pre-
parations from RM, but not SM (Table 2). Thus, the subu-
nit unit 7 of the 26 S proteosome was identified as MSS1
[74], which was shown to be one of the ‘tat’ binding pro-
teins (TBP-1) [34] that regulates HIV-1 transcription by
both by a proteolytic and a non-proteolytic mechanism
[ 4 0 ] .I n t e r e s t i n g l y ,M S S 1h a sa l s ob e e ns h o w nt op l a ya
critical role in regulating CIITA activity and MHC class II
transcription [36]. While preliminary data indicate that the
differential incorporation of MSS-1 by virus replicating
within CD4
+ T cells from RM but not SM could be due to
quantitative differences in the constitutive level of MSS-1
present in RM as compared with SM, the reasons for such
differential intracellular levels is currently under study.
The normal physiological role of the other host proteins
identified has been outlined above in the results section
but their role in promoting disease resistance requires
study. We are cognizant that the disease resistance may
not in fact be related to these differentially identified host
proteins, but could be due to differences in the response
of the host to the proteins that are present in virus pre-
parations from both species and/or due to issues distinct
from the presence of host proteins. However, it is a rea-
sonable hypothesis to pursue.
Finally, it is important to address the role of the sensi-
tivity and specificity of the list of proteins that were
identified. It should be noted that while there were just
3 viral preparations from each of the 2 species, we
chose to utilize highly stringent criteria for inclusion of
these proteins with a high scoring threshold and confi-
dence levels of > 97%. Thus, the inclusion of proteins
being uniquely present in one species and not the other
required for a signature sequence be present in prepara-
tions from all 3 monkeys and that there were a mini-
mum of 3 hits for each protein. We submit that these
are extremely labor intensive studies and require consid-
erable resources for performing such analyses.
Conclusions
Highly sensitive differential proteomic analysis of SIV
preparations from primary CD4
+ T cells from 3 sooty
mangabeys (the natural disease resistant hosts of SIV)
and 3 rhesus macaques (the non-natural disease suscep-
tible hosts) were carried out. These studies led to the
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virus preparations from both rhesus macaques and
s o o t ym a n g a b e y s ,at o t a lo f2 8h o s tp r o t e i n st h a t
uniquely associated with SIV from each of the 3 sooty
mangabeys but none of the rhesus macaques, and 4 host
proteins that were uniquely associated with SIV from
each of the 3 rhesus macaques but none of the sooty
mangabeys. The finding of host proteins such as MSS1
that enhances HIV-1 ‘tat” mediated transactivation
unique to SIV from rhesus macaques and a series of
molecules associated with immune function such as IL-
13 found in SIV from sooty mangabeys provides a rea-
sonable foundation to initiate studies on the potential
link of these unique proteins to the polarized clinical
outcome of SIV infection in these 2 nonhuman primate
species.
Methods
Animals
Peripheral blood samples were obtained from 3 normal
healthy adult rhesus macaques (Macaca mulatta)
denoted as RM and 3 SIV naïve sooty mangabeys (Cer-
cocebus atys) denoted as SM. All monkeys were main-
tained at the Yerkes National Primate Research Center
of Emory University according to the guidelines of the
Committee on the Care and Use of Laboratory Animals
of the Institute of Laboratory Animal Resources,
National Research Council and the Health and Human
Services guidelines “G u i d ef o rt h eC a r ea n dU s eo f
Laboratory Animals.”
Isolation and in vitro infection of PBMCs
PBMCs were isolated from freshly obtained heparinized
peripheral blood by standard gradient centrifugation
using Lymphoprep lymphocyte separation medium
(AXIS-SHIELD PoC AS, Oslo, Norway). The cells were
first depleted of CD8
+ T cells using Dynabeads-CD8
(Invitrogen, Carlsbad, CA) and maintained in vitro in
RPMI 1640 media supplemented with 10% FBS, 2 mM
L-glutamine, 50 μg/ml gentamicin and 50 U/ml IL-2 at
a density of 2 × 10
6 cells/ml.
These in vitro cultured cells were activated by co-culture
with 2 μg/ml Con-A for 72 hours, then washed and trans-
ferred to 50 ml conical tubes and spin inoculated with
SIVdelTable 670 at 1200 × g for 2 hours at room tempera-
ture. The pelleted cells were washed 2× in PBS to remove
residual virus and then cultured at of 2 × 10
6 cells/ml in
RPMI 1640 media supplemented as above. Culture media
was removed every other day after 3 days of culture, and
supernatants cleared by centrifugation at 3220 × g for
20 minutes. A small aliquot of the cultured cells was mon-
itored daily by trypan blue staining to determine the
extent of cell death and cultures were terminated when
the level of dead cells exceeded 30%. Levels of p27 were
quantified for each supernatant sample using SIV p27
Antigen ELISA (ZeptoMetrix Corporation, Buffalo, New
York). Control cultures of CD8
+ depleted PBMCs from
each monkey were maintained in parallel with the SIV
infected samples under identical conditions.
Purification of Virus from Supernatants of Infected Cells
Clarified samples from each of the 3 RM and 3 SM mon-
keys with the highest p27 levels were ultra-centrifuged and
the pelleted virus preparations further purified using the
Fast Trap Lentivirus Purification and Concentration Kit
(Millipore, Billerica, MA) per manufacturer’s instructions.
Briefly, clarified supernatants were further filter purified
and the sample subsequently bound to an anion exchange
membrane. The membrane was washed and the virus
eluted using a high salt buffer. The virus was then concen-
trated and stored in PBS pH 7.4 at -80°C until further use.
Quantitation of p27, the levels of infectivity (TCID50),
number of viral copies and protein concentration
Aliquots of each virus preparation were subjected to a)
determination of the levels of p27 using the commercial
p27 ELISA kit which included a standard that was uti-
lized to calculate the levels of p27 in the specimens, b)
analysis of the relative levels of infectious particles using
the CEM cell line. The TCID50 of each of the virus pre-
paration was calculated by standard end point titration
whereby 2-fold dilutions of the viral preparation were
dispensed in triplicates into individual wells containing
10
5 of the cell line and allowed to incubate for 4 hrs,
washed and then cultured in media and the supernatant
monitored for levels of p27, c) number of viral copies
per ml of the virus preparation using quantitative PCR
and a set of gag primer pairs as described elsewhere
[75,76], and d) quantitation of levels of protein using
the BioRad protein determination kit (BioRad, Hercules,
CA) utilizing the manufacturers protocol. These proce-
dures led to > 100-fold increase in the levels of p27 and
number of viral copies adjusted to 1 mg of protein in
preparations of the virus prior to and post purification
as illustrated in Figure 5A and 5B. Electron microscopic
analysis of the virus preparation similarly demonstrated
a marked enrichment of viral particles and the depletion
of cellular debris (additional file 7).
Protein Identification by Mass Spectrometric Analysis
Protein samples were resolved on a SDS gel and stained
by Coomassie blue. Selected gel regions were excised
(Figure 1) and subjected to in-gel digestion. The result-
ing peptides were analyzed by reverse-phase liquid chro-
matography coupled with tandem mass spectrometry
[77] using an LTQ-Orbitrap mass spectrometer
(Thermo Finnigan, San Jose, CA). The databases
searched were derived from ftp://ftp.ncbi.nih.gov/refseq/
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ject and utilized available primate, rhesus macaque,
sooty mangabey and SIV viral protein sequences.
A strategy of reverse database analysis was used to eval-
uate false discovery rate; the matched peptides were fil-
tered according to matching scores to remove all false
matches from the reverse database [78]. This is a highly
s t r i n g e n tf i l t e rs y s t e me m p l o y e dt om a k es u r et h a tt h e
proteins being identified were in fact present in the viral
preparation. Thus only proteins that were matched by at
least a set of peptides unique to the specific protein in a
single virus preparation were selected for addition to the
resulting virus-host protein database. Results were ana-
lyzed using Microsoft Access.
Immunoblotting
Samples (30 μg of protein per sample) were separated
on SDS-PAGE using a 4-20% gradient ReadyGel (Bio-
Rad), transferred to nitrocellulose membrane (BioRad)
and the membrane blocked with 5% non-fat milk in
T-TBS prior to incubation with the indicated antibody
overnight. After being washed 3 times with T-TBS, the
membrane was incubated with the appropriate second-
ary antibody conjugated to HRP for 1 hour at room
temperature. All bands were visualized using the ECL
detection system (Amersham Biosciences). Equal load-
ing of the samples was determined using anti-b actin
antibodies with each analysis (Sigma). The series of
IL-13 monoclonal antibodies were a generous gift from
Dr. N. Ahlborg of the MabTech corporation (Nacka
Strand, Sweden) and the clone showing the highest
reactivity (clone IL-13-3) against recombinant rhesus
IL-13 was used at a concentration of 1:1000 in T-TBS
containing 5% BSA. Bands for IL-13 were visualized
using anti-rat IgG conjugated to HRP (Southern Bio-
tech, Birmingham, AL). Anti-TLR4 and TLR9 antibo-
dies were purchased from Abcam (Cambridge, MA)
and bands visualized using anti-goat and anti-mouse
IgG conjugated to HRP (Southern Biotech, Birming-
ham, AL), respectively.
Bioassays
The IL-4 and IL-13 dependent B9 cell line was utilized
to determine the presence of biologically active IL-13 in
aliquots of the same viral preparations as were used for
p r o t e o m i ca n a l y s e s .T h eB 9c e l ll i n ew a ss t a r v e do f f
cytokines overnight, washed and 100,000 cells in a
volume of 50 μl of media were then dispensed into indi-
vidual wells of a 96-well microtiter plate. Varying con-
centrations of recombinant human IL-13 was added to
triplicate wells in efforts to derive a standard curve to
be utilized for the quantitation of the level of potential
IL-13 that was present in the viral preparation. The viral
preparation from RM and SM were adjusted to 5 μg/ml
protein concentration and diluted 2-fold in media and
each dilution added in a volume of 50 μl of media to tri-
plicate wells in the presence/absence of 50 μlo fa1 / 1 0
dilution of neutralizing anti-IL13 monoclonal antibody
(known to neutralize 100 ng/ml of recombinant IL-13).
The plates were incubated for 48 hrs in a 7% CO2
humidified atmosphere and 16 hrs prior to harvest each
well was labeled with 1 μCi of methyl-3H-thymidine
and the mean uptake of
3H-thymidine determined. The
lower limit of this assay was determined to be 5 pg/ml.
The ability of the MSS-1 protein to enhance HIV-1
‘tat’ mediated transactivation was utilized by our labora-
tory in efforts to initiate studies on the differential role
of this protein in cells from RM and SM. Briefly, the
M S S - 1w a sf i r s tc l o n e di n t oa ne x p r e s s i o np l a s m i da n d
used in conjunction with a HIV-1 ‘tat’ expression plas-
mid to transfect the standard TZM-bl cells. The amount
of HIV-1 ‘tat’ plasmid to be used in the assay was first
titrated and the level that showed low levels of b-galac-
tosidase activity (0.2 ug of plasmid) chosen. The TZM-
bl cells were seeded in 96-well plates (5000 cell per
well) and transfected with 0.2 ug of the HIV-1 ‘tat’
expression plasmid, 0.8 μg of the MSS1 expression plas-
mid, or both using the Lipofectamine 2000 reagent
(Invitrogen). At 48 h post-transfection, b-galactosidase
activity was determined using the Tropix Gal-Screen
assay kit (Applied Biosystems, Carsbad, CA).
Additional material
Additional file 1: Master list of all host proteins identified. A list of a
total of 1979 host proteins found in virus preparations from any one of
the rhesus macaques and any one of the sooty mangabeys.
Additional file 2: A list of host proteins common to virus
preparations from rhesus macaques and sooty mangabeys. A list of
202 host proteins that were found in virus preparations of CD4
+ T cells
from both rhesus macaques and sooty mangabeys.
Additional file 3: A list of proteins found in common between our
database and those from Chertova et al. [19]. A list of host proteins
that were identified in virus preparations from rhesus macaques and
sooty mangabeys and also by the studies of Chertova et al. [19].
Additional file 4: A list of proteins found in common between our
database and those from Brass et al. [26]. A list of host proteins that
were identified in virus preparations from rhesus macaques and sooty
mangabeys and also by the studies of Brass et al [26].
Additional file 5: A list of proteins found in common between our
database and those from Gautier et al.[30]. A list of host proteins that
were identified in virus preparations from rhesus macaques and sooty
mangabeys and also by the studies of Gautier et al [30].
Additional file 6: A list of proteins found in common between our
database and those from Yeung et al. A list of host proteins that were
identified in virus preparations from rhesus macaques and sooty
mangabeys and also by the studies of Yeung et al. [29].
Additional file 7: Representative Electron micrographs of virus
preparations prior to and post purification. Aliquots of virus preparations
prior to enrichment and following purification/enrichment were pelleted
and the pellets fixed in glutaraldehyde and prepared for thin section
electron micrography. Particles were visualized at 90,000 × and a
representative micrograph prior to (A) and post enrichment (B) is displayed.
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